U.S., April 28 -- ClinicalTrials.gov registry received information related to the study (NCT07552818) titled 'Neuroprotection in Acute Cerebral Ischemia II' on April 20.
Brief Summary: The goal of this clinical trial is to evaluate whether low-frequency, low-intensity transcranial magnetic stimulation (ELF-MF), delivered by the I-NIC medical device, is effective and safe in treating patients with acute ischemic stroke.
The study aims to answer the following questions:
Does ELF-MF stimulation with the I-NIC device improve outcomes in patients with acute cerebral ischemia? Is the treatment safe and well tolerated?
Researchers will compare the I-NIC device to a placebo device (identical in appearance but without active stimulation), both i...